PRIMARY / BOOSTER ANTI-MALARY VACCINE

摘要

The present invention relates to new vaccination regimens, with specific primary / booster vaccination regimens being applied using weakly neutralized recombinant adenoviral vectors containing nucleic acid encoding Plasmodium falciparum antigens and vaccines with purified recombinant protein, such as RTS, S, with matching templates.